US Broker Ratings

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 45% Potential Upside Amidst Robust Revenue Growth

Inspire Medical Systems, Inc. (NYSE: INSP), a notable player in the healthcare sector specializing in medical devices, is gaining significant attention from investors due to its innovative approach to treating..

Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Play with 47% Potential Upside

Waystar Holding Corp. (NASDAQ: WAY) is making significant strides in the healthcare information services sector, capturing the attention of investors with its innovative cloud-based payment solutions. As a company poised..

Option Care Health, Inc. (OPCH) Stock Analysis: A Healthcare Heavyweight with a 12.13% Upside Potential

Option Care Health, Inc. (OPCH) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bannockburn, Illinois, this company has carved out..

Nuvalent, Inc. (NUVL) Stock Analysis: Biotech’s Potential 36.52% Upside Amidst Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a burgeoning player in the biopharmaceutical sector, is drawing significant attention from investors, driven by its promising pipeline of cancer therapies and a robust analyst outlook...

iRhythm Technologies (IRTC) Stock Analysis: A 25% Potential Upside in Healthcare Innovation

iRhythm Technologies, Inc. (NASDAQ: IRTC) is at the forefront of digital healthcare innovation, specializing in ambulatory cardiac monitoring services that diagnose arrhythmias. With a current market capitalization of $5.61 billion,..

Globus Medical, Inc. (GMED) Stock Analysis: Navigating a 13.4% Potential Upside with Innovative Medical Technologies

Globus Medical, Inc. (NYSE: GMED) stands as a beacon of innovation in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $11.76 billion, this Pennsylvania-based..

Viatris Inc. (VTRS) Stock Analysis: Navigating Challenges with a Promising 4.02% Dividend Yield

Viatris Inc. (NASDAQ: VTRS) stands as a significant player in the healthcare sector, particularly within the specialized and generic drug manufacturing industry. With a market capitalization of $13.77 billion, Viatris..

Universal Health Services, Inc. (UHS): Investor Outlook on Healthcare Giant with Over 10% Potential Upside

Universal Health Services, Inc. (UHS), a prominent player in the healthcare sector, stands as a formidable force in the medical care facilities industry in the United States. With a substantial..

Corcept Therapeutics (CORT) Stock Analysis: Potential 51.86% Upside as Biotech Innovator Advances Pipeline

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, continues to capture investor interest with its strong position in the healthcare market. With a current market capitalization..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 14.49% Potential Upside in Medical Devices

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the healthcare sector, specifically within the medical devices industry, boasts a formidable market capitalization of $17.66 billion. Headquartered in Warsaw, Indiana,..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with a 25% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH), a key player in the healthcare sector, specializes in developing and commercializing diagnostic and therapeutic products. With a focus on heart and cancer diagnostics, Lantheus..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Potential and Performance Challenges in the Healthcare Sector

Medpace Holdings, Inc. (NASDAQ: MEDP) has been a noteworthy player in the healthcare sector, particularly within the diagnostics and research industry. With a market cap of $16.01 billion, Medpace offers..

Bio-Techne Corp (TECH) Stock Analysis: Why a 19.56% Upside Beckons Investors

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology sector, stands as a compelling opportunity for investors seeking exposure to the healthcare industry. With a market capitalization of $9.08..

ADMA Biologics Inc (ADMA) Stock Analysis: Strong Analyst Consensus and 31% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company specializing in plasma-derived biologics, is capturing the attention of investors with its robust growth potential and strong market performance. Currently headquartered in..

Repligen Corporation (RGEN) Stock Analysis: Exploring a Potential 16.53% Upside in the Booming Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of $9.14 billion, Repligen is..

Qiagen N.V. (QGEN) Stock Report: Exploring a 10.95% Potential Upside in the Diagnostics & Research Sector

For investors keen on the healthcare sector, Qiagen N.V. (NYSE: QGEN) offers a compelling opportunity with a market cap of $9.88 billion. Specializing in diagnostics and research, Qiagen is a..

Johnson & Johnson (JNJ) Stock Analysis: Poised for Steady Growth with a 1.42% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to present a promising opportunity for investors seeking stability and growth in a volatile market. With a market..

Charles River Laboratories (CRL) Stock Analysis: Is the Market Overlooking This Healthcare Giant?

Charles River Laboratories International, Inc. (CRL), a prominent player in the healthcare sector’s diagnostics and research industry, is drawing attention with its robust market presence and strategic collaborations. With a..

Glaukos Corporation (GKOS) Stock Analysis: Investor Confidence Grows with Strong Buy Ratings

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, particularly in the medical devices industry, is drawing considerable interest from investors. With a market capitalization of $6.68 billion,..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating a High-Growth Path in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS) stands at the forefront of the healthcare sector, specifically within diagnostics and research. With a market capitalization of $19.32 billion, the company has carved a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds